ANTI-INFECTIVE DRUGS ADVISORY COMMITTEE

October 16, 2001

Drotrecogin Alfa (ACTIVATES) [RECOMBINANT HUMAN ACTIVATED PROTEIN C (rhAPC)]

XiGRIS™, BLA #125029/0

Briefing Information

FDA

FDA Briefing Information   pdf   doc

ELI LILLY AND COMPANY

Disclaimer

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Sponsor Briefing Information   pdf   htm